Companies › INNV
INNOVAGE HLDG CORP (INNV)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001834376 · EDGAR filings · Updated 2026-07-27
INNOVAGE HLDG CORP (INNV) has reported institutional ownership of 11.8%, with 102 institutional managers holding positions valued at $128.0M per the latest 13F reporting period.
Filings this week (4)
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-23 — Insider transaction reported (Form 4)
- 2026-07-23 — Insider transaction reported (Form 4)
- 2026-07-23 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, INNOVAGE HLDG CORP has 102 institutional holders and institutional ownership of 11.8%.
Insider activity
Insiders reported 30 transactions (11 buys, 1 sells) across 10 reporting insiders, with a net reported value of $159.1K.
Related companies
INFUSYSTEM HLDGS INC (INFU) · VOYAGER THERAPEUTICS INC (VYGR) · QUANTERIX CORP (QTRX) · EDITAS MEDICINE INC (EDIT) · HERON THERAPEUTICS INC (HRTX) · MACROGENICS INC (MGNX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.